Outcome of African American men screened for prostate cancer: The Detroit Education and Early Detection Study

Journal of Urology

Volumn 158, Issue 1, 1997, Pages 146-149

  Powell, Isaac J ^a   Heilbrun, Lance ^a   Littrup, Peter L ^a   Franklin, Archilind ^a   Parzuchowski, Jean ^a   Gelfand, Donald ^a   Sakr, Wael ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blacks; Carcinoma; Diagnosis; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CAUCASIAN; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RECURRENT CANCER; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0030987759     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199707000-00045     Document Type: Article

References (21)

1. Wingo, P. A., Tong, T. and Bolden, S.: Cancer statistics, 1995. CA, 45: 8, 1995.
2. Ries, L. A. G., Miller, B. A., Hankey, B. F., Kosary, C. L., Harras, A. and Edwards, B. K.: SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. National Institutes of Health Publication No. 94-2789. Bethesda, Maryland: Public Health Service, United States Department of Health and Human Services, 1994.
3. Current trends: trends in prostate cancer - United States, 1980-1988. Morbid. Mortal. Week. Rep., 41: 401, 1992.
4. Michigan Department of Public Health: Cancer Incidence Mortality, pp. 3-13, 1992.
5. Cancer of the Prostate. Bethesda, Maryland: Office of Cancer Communications, National Cancer Institute, 1990.
6. Powell, I. J., Schwartz, K. and Hussain, M.: Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology, 46: 825, 1995.
7. Brawn, P. N., Johnson, E. H., Kuhl, D. L., Riggs, M. W., Speights, V. O., Johnson, C. F., III, Pandya, P. P., Lind, M. L. and Bell, N. F.: Stage at presentation and survival of white and black patients with prostate carcinoma. Cancer, 71: 2569, 1993.
8. Powell, I. J., Gelfand, D. E., Parzuchowski, J., Heilbrun, L. and Franklin, A.: A successful recruitment process of African American men for early detection of prostate cancer. Cancer, 75: 1880, 1995.
9. Mettlin, C., Lee, F., Drago, J. and Murphy, G. P.: The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2,425 men. Cancer, 67: 2949, 1991.
10. Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vassella, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
11. Catalona, W. J., Richie, J. P., Ahman, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalhin, B. L., Waters, W. B., McFarland, M. T. and Southwick, P. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
12. Demark-Wahnefried, W., Catoe, K. E., Paskett, E., Robertson, C. N. and Rimer, B. K.: Characteristics of men reporting for prostate cancer screening. Urology, 42: 269, 1993.
13. Oesterling, J. E., Jacobsen, S. J., Chute, C. G., Guess, H. A., Griman, C. J., Pauser, L. A. and Lieber, M. M.: Serum prostate-specific antigen in a community-based population of health men. Establishment of age-specific reference ranges. J.A.M.A., 270: 860, 1993.
14. Forman, J. D., Ruby, J., Parzuchowski, J., Littrup, P., Porter, A. T. and Powell, I.: Earlier detection of prostate cancer in African American men treated with radiotherapy: results of a targeted screening program. Rad. Oncol. Invest. 4: 80, 1996.
15. Scardino, P. T., Weaver, R. and Hudson, M. A.: Early detection of prostate cancer. Hum. Path., 23: 211, 1992.
16. Kramer, B. S., Brown, M. L., Prorok, P. C., Potosky, A. L. and Gohagan, J. K.: Prostate cancer screening: what we know and what we need to know. Ann. Intern. Med., 119: 914, 1993.
17. Catalona, W. J.: Screening for prostate cancer: enthusiasm. Urology, 42: 113, 1993.
18. Ibrahim, G. K., Coetzee, L. J. and Paulson, D. F.: Outcome of surgical therapy for clinically localized prostatic adenocarcinoma: Caucasian and Afro-Americans. J. Urol., part 2, 153: 504A, abstract 1101, 1995.
19. Fleming, C., Wasson, J. H., Albertsen, P. C., Barry, M. J. and Wennberg, J. E. for the Prostate Outcomes Research Team: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. J.A.M.A., 269: 2650, 1993.
20. Krahn, M. D., Mahoney, J. E., Eckman, M. H., Trachtenberg, J., Pauker, S. G. and Detsky, A. S.: Screening for prostate cancer: a decision analytic view. J.A.M.A., 272: 773, 1994.
21. Brawer, M. K.: How to use prostate-specific antigen in the early detection or screening for prostatic carcinoma. CA, 45:148, 1995.